Scientists Discover Hybrid Brain Cells Linked to Multiple Sclerosis

Summary

The human brain relies on a highly specialized workforce to stay healthy. For a long time, scientists neatly categorized these cellular workers. Microglia act as the immune and cleanup crew, while oligodendrocytes manufacture myelin, the protective insulation that coats nerve fibers. Now, researchers have discovered a fascinating hybrid. By looking at the genetic instructions of individual cells, they identified dual-phenotype microglia, or DPM. These unique cells simultaneously show the traits of both the immune cleanup crew and the insulation manufacturers.

The research team found that these hybrid cells come in two distinct varieties, each with its own job and location. The first type, called myelin-associated DPM, is scattered throughout the entire brain. Controlled by a genetic switch known as Sox10, these highly branched cells help maintain nerve insulation. The second type, neuron-associated DPM, operates quite differently. Governed by a different genetic controller called Glis2, these cells cluster tightly in the hippocampus, a brain region crucial for memory. There, they help regulate the delicate communication networks between neurons.

To make this discovery, scientists used a technique called single-cell transcriptomics, which allows them to read the exact genetic activity of individual cells alongside advanced physical mapping tools. While the findings are exciting, the researchers note that this is still early-stage preclinical work. The current study clearly maps out the genetics and physical locations of these hybrid cells, but further research in living models is required to fully confirm how they operate in a functioning brain.

Why it matters.

This discovery could fundamentally shift how we understand and treat major neurodegenerative diseases. The researchers observed that these hybrid cells are deeply intertwined with brain pathology, particularly in multiple sclerosis and Alzheimer's disease. Most notably, they found that the myelin-associated hybrid cells cluster specifically in active multiple sclerosis lesions. Multiple sclerosis is a disease defined by the immune system destroying nerve insulation, so finding a cell that naturally possesses both immune and insulation-related qualities right at the site of damage is a major clue for scientists trying to understand brain repair.

Globally, millions of people live with multiple sclerosis and Alzheimer's disease, and current treatments often struggle to halt disease progression or restore lost function. By identifying a previously unknown cellular player, this research provides the medical field with a brand-new target for drug development. If future studies can figure out how to safely activate or support these hybrid cells, it could eventually lead to next-generation therapies that harness the brain's own built-in maintenance crew to repair nerve damage and protect cognitive function.

From the source

The story in numbers.

Distinct subtypes of dual-phenotype microglia (DPM) identified: 2
Key stages in the proposed functional modeling of DPM: 4

Keep the context

Follow the evidence.

This source is a preprint and has not completed peer review. Its findings are provisional.

Swapping RNA for DNA gives CRISPR a powerful new target

The gene-editing tool known as CRISPR has revolutionized biology, traditionally relying on a molecule called guide RNA to direct molecular scissors to a specific piece of DNA. However, researchers have discovered a surprising twist. A specific type of molecular scissors known as a Cas12 nuclease can actually be driven by a different genetic navigator. Instead of using traditional guide RNA, this enzyme can utilize guide DNA. This simple substitution fundamentally changes how the tool behaves in a cell. When scientists swap the guide RNA for guide DNA, the Cas12 nuclease stops targeting DNA and instead switches its focus to targeting RNA. RNA is the genetic messenger that helps carry instructions from our genes to the rest of the cell. By just changing the steering mechanism, scientists can completely redirect the cutting machinery to a brand new molecular target. While this discovery significantly expands the overall versatility of the CRISPR toolkit, it is still very preliminary. The current reports are based on an early-stage perspective and lack the quantitative data, clinical validation, and sample size metrics needed to fully understand how well it works in complex organisms.

Nature Biotechnology1 min read

Blood Immune Cells May Drive Spinal Cord Damage in ALS

Amyotrophic lateral sclerosis (ALS) is a severe condition that causes a progressive loss of nerve cells in the brain and spinal cord. While scientists have spent decades studying why these neurons fail, recent research published in Nature Neuroscience points to an unexpected culprit. The study reveals that the immune system is not merely reacting to the disease, but actually acts as an active driver of ALS pathology. To uncover this, researchers used advanced techniques called single-cell and spatial transcriptomic profiling. These tools allow scientists to look at the genetic activity of individual cells and map their exact physical locations in the body. Using these methods, the team observed that immune cells from the bloodstream are infiltrating the central nervous system. Once there, these immune cells undergo a reprogramming process that directly links changes in the blood to the severe spinal cord damage seen in ALS patients.

Nature Neuroscience1 min read

A Domino Effect: How the Immune System Accelerates ALS

Amyotrophic lateral sclerosis, commonly known as ALS, is a devastating disease that gradually destroys the nerve cells responsible for movement. For years, scientists have puzzled over why the condition progresses rapidly in some patients while others survive much longer. Now, researchers at Northwestern University have uncovered a domino-like cascade that helps explain how the disease unfolds. Rather than a single catastrophic event, ALS appears to start with an internal breakdown inside motor neurons involving a toxic buildup of a protein called TDP-43. This initial damage then triggers a secondary, highly destructive response from the body's own immune system. By examining blood and spinal cord samples from hundreds of living and deceased patients, the scientists mapped out exactly where and how this immune reaction occurs. They discovered that inflamed immune cells from the bloodstream travel into the central nervous system, gathering directly at the sites where motor neurons are dying and toxic proteins are accumulating. Patients with the fastest disease progression had the most intense spinal cord inflammation and higher activity in complement genes, which produce proteins that act as the body's first line of immune defense against damage. Interestingly, the study also revealed that this immune response looks different depending on the root cause of the patient's condition. By analyzing the genetic instructions inside individual cells, the researchers found distinct immune patterns when comparing genetic and non-genetic forms of ALS. This suggests that the immune system reacts uniquely to different variations of the disease.

GEN2 min read

Follow your curiosity.

Scientists Discover Hybrid Brain Cells Linked to Multiple Sclerosis

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Swapping RNA for DNA gives CRISPR a powerful new target

Blood Immune Cells May Drive Spinal Cord Damage in ALS

A Domino Effect: How the Immune System Accelerates ALS

Summary

Why it matters.

The story in numbers.

Follow the evidence.

Your next discovery.

Swapping RNA for DNA gives CRISPR a powerful new target

Blood Immune Cells May Drive Spinal Cord Damage in ALS

A Domino Effect: How the Immune System Accelerates ALS

A little science goes a long way.